Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis.

Daniel H SolomonJon T GilesKatherine P LiaoPaul M RidkerPamela M RistRobert J GlynnRachel BroderickFengxin LuMeredith T MurrayKathleen VanniLeah M SantacroceShady AbohashemPhilip M RobsonZahi FayadVenkatesh ManiAhmed TawakolJoan Bathonnull null

Published in: Annals of the rheumatic diseases (2022)

NCT02374021.

Keyphrases

study protocol
clinical trial
open label
phase iii
phase ii
double blind
placebo controlled
randomized controlled trial